NSPR

Marvin Slosman

Known title: CEO and PresidentCIK: 0001796908

Marvin Slosman's purchase track record

Marvin Slosman has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
5/12/2026NSPR$25K-28.3%pending
7/30/2025NSPR$25K-4.2%-30.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

InspireMD (NSPR) noted in pre‑market health‑care stock moves. NSPR was listed among twelve health‑care companies showing price action in Friday’s pre‑market session, according to Benzinga. The move comes while the stock’s RSI is low at 25.7 and it is near its $0.70 support level, suggesting continued pressure. Such activity may reflect renewed trader attention despite the broader market context.

this person other insiders at NSPR

Transaction History

NSPR▲ Buy$25K
NSPR▲ Buy$0
NSPR▲ Buy$25K
NSPR▲ Buy$0
NSPR▲ Buy$0
NSPR▲ Buy$0
NSPR▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.